All companies
Visit website
REUZEIT
OperatingREUZEit, Inc.
Healthcare · Founded 2020
Circular economic surplus asset management
Post-money valuation ⓘ
$40.2M
As of Feb 2023 · from REUZEit Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$159,676
Across 1 round since 2022
Latest share price
$0.80
REUZEit Common Stock 1 offering price
Financials
FY2020–FY2022 · from SEC filings · hover any figure for its source$6.9M
$910K
2020
$6.4M
−$279K
2021
$7.8M
−$385K
2022
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
Income statement
Revenue
$6,884,892
$6,420,789
$7,801,733
Cost of goods sold
$3,190,768
$3,296,877
$2,981,614
Gross margin
54%
49%
62%
Net income
$910,436
-$278,668
-$384,847
Taxes paid
$115,611
$32,620
$641
Balance sheet
Cash
$566,326
$378,941
$327,379
Accounts receivable
$348,369
$713,164
$1,990,824
Total assets
$1,553,762
$2,164,354
$3,592,235
Short-term debt
$663,847
$1,367,104
$1,767,175
Long-term debt
$141,228
$261,034
$1,529,687
Total liabilities
$805,075
$1,628,138
$3,296,862
Other
Headcount
—
27
27
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$40.2M
post-money
REUZEit Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $159.7K / $1.2MInvestors 68Post-money $40.2M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 1 of 4 annual reports (FY2022–FY2025)
68 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001949602Share price $0.80
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.